Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.4 Scope of Type
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 Actelion Pharmaceuticals Ltd
  • 3.1.1 Company Information
  • 3.1.2 Product & Services
  • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.1.4 Recent Development
• 3.2 Eisai Co Ltd
  • 3.2.1 Company Information
  • 3.2.2 Product & Services
  • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.2.4 Recent Development
• 3.3 Evotec AG
  • 3.3.1 Company Information
  • 3.3.2 Product & Services
  • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.3.4 Recent Development
• 3.4 Heptares Therapeutics Ltd
  • 3.4.1 Company Information
  • 3.4.2 Product & Services
  • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.4.4 Recent Development
• 3.5 Idorsia Ltd
  • 3.5.1 Company Information
  • 3.5.2 Product & Services
  • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.5.4 Recent Development
• 3.6 Johnson & Johnson
  • 3.6.1 Company Information
  • 3.6.2 Product & Services
  • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.6.4 Recent Development
• 3.7 Merck & Co Inc
  • 3.7.1 Company Information
  • 3.7.2 Product & Services
  • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.7.4 Recent Development
• 3.8 OptiNose US Inc
  • 3.8.1 Company Information
  • 3.8.2 Product & Services
  • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.9 Yangtze River Pharmaceutical Group
  • 3.9.1 Company Information
  • 3.9.2 Product & Services
  • 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application

• 4.1 Insomnia
  • 4.1.1 Overview
  • 4.1.2 Insomnia Market Size and Forecast
• 4.2 Narcolepsy
  • 4.2.1 Overview
  • 4.2.2 Narcolepsy Market Size and Forecast
• 4.3 Sleep Disorders
  • 4.3.1 Overview
  • 4.3.2 Sleep Disorders Market Size and Forecast
• 4.4 Major Depressive Disorder
  • 4.4.1 Overview
  • 4.4.2 Major Depressive Disorder Market Size and Forecast

5 Market by Type

5.By HTL-6641

• 5.1 HTL-6641
  • 5.1.1 Overview
  • 5.1.2 HTL-6641 Market Size and Forecast
• 5.2 MK-8133
  • 5.2.1 Overview
  • 5.2.2 MK-8133 Market Size and Forecast
• 5.3 Lemborexant
  • 5.3.1 Overview
  • 5.3.2 Lemborexant Market Size and Forecast
• 5.4 OPN-021
  • 5.4.1 Overview
  • 5.4.2 OPN-021 Market Size and Forecast
• 5.5 YNT-185
  • 5.5.1 Overview
  • 5.5.2 YNT-185 Market Size and Forecast
• 5.6 Others
  • 5.6.1 Overview
  • 5.6.2 Others Market Size and Forecast

6 Price Overview

• 6.1 Price by Manufacturers
• 6.2 Price by Application
• 6.3 Price by Type

7 Conclusion

Summary
The global Orexin Receptor Type 2 market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Actelion Pharmaceuticals Ltd
Eisai Co Ltd
Evotec AG
Heptares Therapeutics Ltd
Idorsia Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Yangtze River Pharmaceutical Group
Major applications as follows:
Insomnia
Narcolepsy
Sleep Disorders
Major Depressive Disorder
Major Type as follows:
HTL-6641
MK-8133
Lemborexant
OPN-021
YNT-185
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa